STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3608 by analyst upside · 2026-08-12
PDEX
Pro-Dex, Inc.
Healthcare · Market Cap $213M · P/E 18.4x
ANALYST PRICE TARGET
+4.9%
implied upside to consensus target
Current Price $66.72
Consensus Target $70.0
Bull Target $70.0
Bear Target $70.0
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $23.47
52-Week High $68.99
YTD Return +76.9%
FUNDAMENTALS
Market Cap $213M
P/E Ratio (TTM) 18.4x
Forward P/E 32.4x
EPS (TTM) $3.63
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $75M
Profit Margin 16.1%
52-WEEK RANGE
52-Week Low $23.47
52-Week High $68.99
Current Price $66.72
Bear Target $70.0
Bull Target $70.0
● Now $66.72 ● Target $70.0
TRADING DATA
Avg Volume 78K
YTD Return +76.9%
Analyst Count 1
Consensus Buy
Upside to Target +4.9%
Last Updated 2026-08-12

ANALYST SUMMARY

Pro-Dex, Inc. (PDEX) is currently trading at $66.72 with a Wall Street consensus price target of $70.0, implying potential upside of 4.9% over the next 12 months. 1 analysts currently cover PDEX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $70.0, while the most cautious has a target of $70.0.

PDEX operates in the Healthcare sector with a market capitalisation of $213M. The stock is up 76.9% year-to-date and is currently trading near the upper end of its 52-week range of $23.47 – $68.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PDEX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital - Reiterated
Buy → Buy 2026-05-12 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-05-27 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-02-22 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2024-11-11 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2024-09-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →